Evaluation of oral anticoagulants in atrial fibrillation patients over 80 years of age with nonsevere frailty.
Masaya ShinoharaRyou WadaShintaro YaoKensuke YanoKatsuya AkitsuHideki KoikeToshio KinoshitaHitomi YuzawaTakeya SuzukiTadashi FujinoTakanori IkedaPublished in: Journal of arrhythmia (2019)
OACs are substantially safe and effective for preventing thromboembolic events in nonsevere frail patients over 80 years of age. Particularly, DOACs can be used more safely than warfarin.